Peptide Nucleic Acid - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509241949

Publication Date:

September 6, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

The global market for Peptide Nucleic Acid was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
PNA can be used as a specific probe for DNA and RNA for genomics and proteomics research. PNA probes have high specificity and affinity and can accurately detect specific DNA or RNA sequences, so they have broad application prospects in the fields of genetic diagnosis, gene therapy, and gene expression regulation. PNA can also be used as a drug molecule to treat certain diseases. For example, PNA can bind to specific mRNA sequences, thereby preventing its translation into proteins, thereby achieving the purpose of treating diseases. In addition, PNA can also be used as antisense nucleic acid drugs to treat certain genetic diseases and cancers.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Peptide Nucleic Acid, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Peptide Nucleic Acid by region & country, by Type, and by Application.
The Peptide Nucleic Acid market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Nucleic Acid.
麻豆原创 Segmentation
By Company
Abbott Molecular
PerkinElmer
SciGene Corporation
Roche NimbleGen
CytoTest
LifeTein
Segment by Type:
Double Chain
Single Chain
Segment by Application
Gene Chip
Electrophoresis
Fluorescence In Situ Hybridization
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Peptide Nucleic Acid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Peptide Nucleic Acid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Peptide Nucleic Acid in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Peptide Nucleic Acid Product Introduction
1.2 Global Peptide Nucleic Acid 麻豆原创 Size Forecast
1.2.1 Global Peptide Nucleic Acid Sales Value (2019-2030)
1.2.2 Global Peptide Nucleic Acid Sales Volume (2019-2030)
1.2.3 Global Peptide Nucleic Acid Sales Price (2019-2030)
1.3 Peptide Nucleic Acid 麻豆原创 Trends & Drivers
1.3.1 Peptide Nucleic Acid Industry Trends
1.3.2 Peptide Nucleic Acid 麻豆原创 Drivers & Opportunity
1.3.3 Peptide Nucleic Acid 麻豆原创 Challenges
1.3.4 Peptide Nucleic Acid 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Peptide Nucleic Acid Players Revenue Ranking (2023)
2.2 Global Peptide Nucleic Acid Revenue by Company (2019-2024)
2.3 Global Peptide Nucleic Acid Players Sales Volume Ranking (2023)
2.4 Global Peptide Nucleic Acid Sales Volume by Company Players (2019-2024)
2.5 Global Peptide Nucleic Acid Average Price by Company (2019-2024)
2.6 Key Manufacturers Peptide Nucleic Acid Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Peptide Nucleic Acid Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Peptide Nucleic Acid
2.9 Peptide Nucleic Acid 麻豆原创 Competitive Analysis
2.9.1 Peptide Nucleic Acid 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Peptide Nucleic Acid Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Nucleic Acid as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Double Chain
3.1.2 Single Chain
3.2 Global Peptide Nucleic Acid Sales Value by Type
3.2.1 Global Peptide Nucleic Acid Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Peptide Nucleic Acid Sales Value, by Type (2019-2030)
3.2.3 Global Peptide Nucleic Acid Sales Value, by Type (%) (2019-2030)
3.3 Global Peptide Nucleic Acid Sales Volume by Type
3.3.1 Global Peptide Nucleic Acid Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Peptide Nucleic Acid Sales Volume, by Type (2019-2030)
3.3.3 Global Peptide Nucleic Acid Sales Volume, by Type (%) (2019-2030)
3.4 Global Peptide Nucleic Acid Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Gene Chip
4.1.2 Electrophoresis
4.1.3 Fluorescence In Situ Hybridization
4.2 Global Peptide Nucleic Acid Sales Value by Application
4.2.1 Global Peptide Nucleic Acid Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Peptide Nucleic Acid Sales Value, by Application (2019-2030)
4.2.3 Global Peptide Nucleic Acid Sales Value, by Application (%) (2019-2030)
4.3 Global Peptide Nucleic Acid Sales Volume by Application
4.3.1 Global Peptide Nucleic Acid Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Peptide Nucleic Acid Sales Volume, by Application (2019-2030)
4.3.3 Global Peptide Nucleic Acid Sales Volume, by Application (%) (2019-2030)
4.4 Global Peptide Nucleic Acid Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Peptide Nucleic Acid Sales Value by Region
5.1.1 Global Peptide Nucleic Acid Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Peptide Nucleic Acid Sales Value by Region (2019-2024)
5.1.3 Global Peptide Nucleic Acid Sales Value by Region (2025-2030)
5.1.4 Global Peptide Nucleic Acid Sales Value by Region (%), (2019-2030)
5.2 Global Peptide Nucleic Acid Sales Volume by Region
5.2.1 Global Peptide Nucleic Acid Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Peptide Nucleic Acid Sales Volume by Region (2019-2024)
5.2.3 Global Peptide Nucleic Acid Sales Volume by Region (2025-2030)
5.2.4 Global Peptide Nucleic Acid Sales Volume by Region (%), (2019-2030)
5.3 Global Peptide Nucleic Acid Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Peptide Nucleic Acid Sales Value, 2019-2030
5.4.2 North America Peptide Nucleic Acid Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Peptide Nucleic Acid Sales Value, 2019-2030
5.5.2 Europe Peptide Nucleic Acid Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Peptide Nucleic Acid Sales Value, 2019-2030
5.6.2 Asia Pacific Peptide Nucleic Acid Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Peptide Nucleic Acid Sales Value, 2019-2030
5.7.2 South America Peptide Nucleic Acid Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Peptide Nucleic Acid Sales Value, 2019-2030
5.8.2 Middle East & Africa Peptide Nucleic Acid Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Peptide Nucleic Acid Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Peptide Nucleic Acid Sales Value
6.2.1 Key Countries/Regions Peptide Nucleic Acid Sales Value, 2019-2030
6.2.2 Key Countries/Regions Peptide Nucleic Acid Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Peptide Nucleic Acid Sales Value, 2019-2030
6.3.2 United States Peptide Nucleic Acid Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Peptide Nucleic Acid Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Peptide Nucleic Acid Sales Value, 2019-2030
6.4.2 Europe Peptide Nucleic Acid Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Peptide Nucleic Acid Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Peptide Nucleic Acid Sales Value, 2019-2030
6.5.2 China Peptide Nucleic Acid Sales Value by Type (%), 2023 VS 2030
6.5.3 China Peptide Nucleic Acid Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Peptide Nucleic Acid Sales Value, 2019-2030
6.6.2 Japan Peptide Nucleic Acid Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Peptide Nucleic Acid Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Peptide Nucleic Acid Sales Value, 2019-2030
6.7.2 South Korea Peptide Nucleic Acid Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Peptide Nucleic Acid Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Peptide Nucleic Acid Sales Value, 2019-2030
6.8.2 Southeast Asia Peptide Nucleic Acid Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Peptide Nucleic Acid Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Peptide Nucleic Acid Sales Value, 2019-2030
6.9.2 India Peptide Nucleic Acid Sales Value by Type (%), 2023 VS 2030
6.9.3 India Peptide Nucleic Acid Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott Molecular
7.1.1 Abbott Molecular Company Information
7.1.2 Abbott Molecular Introduction and Business Overview
7.1.3 Abbott Molecular Peptide Nucleic Acid Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Abbott Molecular Peptide Nucleic Acid Product Offerings
7.1.5 Abbott Molecular Recent Development
7.2 PerkinElmer
7.2.1 PerkinElmer Company Information
7.2.2 PerkinElmer Introduction and Business Overview
7.2.3 PerkinElmer Peptide Nucleic Acid Sales, Revenue and Gross Margin (2019-2024)
7.2.4 PerkinElmer Peptide Nucleic Acid Product Offerings
7.2.5 PerkinElmer Recent Development
7.3 SciGene Corporation
7.3.1 SciGene Corporation Company Information
7.3.2 SciGene Corporation Introduction and Business Overview
7.3.3 SciGene Corporation Peptide Nucleic Acid Sales, Revenue and Gross Margin (2019-2024)
7.3.4 SciGene Corporation Peptide Nucleic Acid Product Offerings
7.3.5 SciGene Corporation Recent Development
7.4 Roche NimbleGen
7.4.1 Roche NimbleGen Company Information
7.4.2 Roche NimbleGen Introduction and Business Overview
7.4.3 Roche NimbleGen Peptide Nucleic Acid Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Roche NimbleGen Peptide Nucleic Acid Product Offerings
7.4.5 Roche NimbleGen Recent Development
7.5 CytoTest
7.5.1 CytoTest Company Information
7.5.2 CytoTest Introduction and Business Overview
7.5.3 CytoTest Peptide Nucleic Acid Sales, Revenue and Gross Margin (2019-2024)
7.5.4 CytoTest Peptide Nucleic Acid Product Offerings
7.5.5 CytoTest Recent Development
7.6 LifeTein
7.6.1 LifeTein Company Information
7.6.2 LifeTein Introduction and Business Overview
7.6.3 LifeTein Peptide Nucleic Acid Sales, Revenue and Gross Margin (2019-2024)
7.6.4 LifeTein Peptide Nucleic Acid Product Offerings
7.6.5 LifeTein Recent Development
8 Industry Chain Analysis
8.1 Peptide Nucleic Acid Industrial Chain
8.2 Peptide Nucleic Acid Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Peptide Nucleic Acid Sales Model
8.5.2 Sales Channel
8.5.3 Peptide Nucleic Acid Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Abbott Molecular
PerkinElmer
SciGene Corporation
Roche NimbleGen
CytoTest
LifeTein

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.